Xolair and Choledocholithiasis - a phase IV clinical study of FDA data

Summary:

Choledocholithiasis is reported as a side effect among people who take Xolair (omalizumab), especially for people who are female, 60+ old, also take Advair Hfa, and have Dyspnea.

The phase IV clinical study analyzes which people have Choledocholithiasis when taking Xolair. It is created by eHealthMe based on reports of 77,224 people who have side effects when taking Xolair from the FDA, and is updated regularly.

What is Xolair?

Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.

What is Choledocholithiasis?

Choledocholithiasis (stones in the common bile duct) is found to be associated with 606 drugs and 959 conditions by eHealthMe. Check the latest studies of Choledocholithiasis.

On Jul, 20, 2026

77,224 people reported to have side effects when taking Xolair.
Among them, 24 people (0.03%) have Choledocholithiasis.

Among these 24 people:

What is the gender of people who have Choledocholithiasis when taking Xolair? *

female: 95.65 %
male: 4.35 %

What is the age of people who have Choledocholithiasis when taking Xolair? *

What are other drugs people take besides Xolair? *

What are other side effects people have besides Choledocholithiasis? *

Malaise (a feeling of general discomfort or uneasiness): 17 people, 70.83%
Dyspnea (difficult or laboured breathing): 16 people, 66.67%
Sputum Discolored: 12 people, 50.00%
Nasopharyngitis (inflammation of the nasopharynx): 12 people, 50.00%
Productive Cough: 11 people, 45.83%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 45.83%
Sinusitis (inflammation of sinus): 11 people, 45.83%
Influenza Like Illness: 11 people, 45.83%
Blood Pressure Systolic Increased: 10 people, 41.67%
Back Pain: 10 people, 41.67%

What are the existing conditions these people have? *

Heart Valve Incompetence (heart's valves do not work correctly): 8 people, 33.33%
Dyspnea (difficult or laboured breathing): 8 people, 33.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 4.17%
Sense Of Oppression (sense of heavy burden): 1 person, 4.17%
Rashes (redness): 1 person, 4.17%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 4.17%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.17%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.17%
Drug Hypersensitivity: 1 person, 4.17%
Acne (skin problems that cause pimples): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Xolair and have Choledocholithiasis?

- Check whether Choledocholithiasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xolair:

Xolair (77,554 reports)

Browse all side effects of Xolair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Choledocholithiasis:

Choledocholithiasis (606 drugs)

Browse all the conditions that are associated with Choledocholithiasis:

Choledocholithiasis (959 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omalizumab (the active ingredients of Xolair) and Xolair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.